Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,003 recalls · newest first
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Misprint on tablet
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Misprint on tablet
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Labeling: Incorrect or Missing Lot and/or Exp Date.
CGMP Deviations: products may not conform to the labeled specifications.
CGMP Deviations: products may not conform to the labeled specifications.
Failed Impurities/Degradation Specification: Out of specification for organic impurities
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Subpotent Drug
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Failed Dissolution Specifications
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Failed Impurities/Degradation Specification.
Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of…
Lack of Sterility Assurance: Aseptic process simulation failure.